Local anaesthetics Flashcards

1
Q

Chemistry

A

Analogues of cocaine
Hydrophobic group (aromatic) and ionisable group (e.g. amine)
Linked by ester/amide bond
Weak base (exist as B and BH+)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Permanently charged LA

A

QX-314 and QX-222
Useful for experiments - mechanism of action of local anaesthetics
Analogues of lidocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Widely used LA

A

Procaine, lidocaine, bupivacaine, amethocaine, tetracaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Procaine

A
Potency = 1
Duration = short
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Tetracaine

A
Potency = 16 
Duration = long
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Lidocaine

A

Potency = 4
Duration = med
Amine
pKa = 7.9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Bupivacaine

A

Potency = 16
Duration = long
Epidural

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Amethocaine

A

Cream when take blood

Eye drop after cataract surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mechanism of action

A
Block initiation and propagation of action potentials - block voltage gated Na+ channels
Binding site in channel pore 
Threshold potential not reached 
Lose sensation  
Bind reversibly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Physiological pain circuits

A

Harmful stimuli sensed by specialised nerve fibres:
Unmyelinated C, thinly myelinated Aδ (both narrow)
Physiochemical properties convert to electrical by transient receptor potential (TRP) + purinergic channels
Electrical activity amplify by Na+ channels = action potentials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

pH

A

LA = Weak base (exist as B and BH+)

Ratio between ionised and non-ionised drug in tissue depends on pH and pKa of drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Henderson-Hasselbalch equation (pH)

A

pKa-pH = log[BH+]/[B]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Equilibrium (pH)

A

Want most drug outside cell = unionised - travel through membrane
Want most drug in cell = ionised - block channel
Achieve w/ diff. pH in and out

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Factors influencing the activity of LA

A

pKa, pH, lipid solubility, intermediate chaine, protein binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Factors influencing the activity of LA: pKa

A

pKa: ph when no. ionised drug = no. unionised (equilibrium)

More unionised present for given pH = faster onset action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Factors influencing the activity of LA: pH

A

Lower pH = lower potency
In acidic conditions - more ionised, less LA can cross lipid bilayer and block V-G Na+ channel
Worse reduction of pain in infected tissues (e.g. abscesses) - highly acidic, all LA ionised, not cross membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Factors influencing the activity of LA: Lipid solubility

A

More lipid soluble = higher potency = faster onset action = longer duration
More drug cross lipid bilayer of neuronal membrane, create store of drug in axoplasm

18
Q

Factors influencing the activity of LA: Intermediate chain

A

Longer = higher potency

E.g. bipuvacaine has longer chain than lidocaine, more potent

19
Q

Factors influencing the activity of LA: protein binding

A

Higher degree of protein binding = longer duration

20
Q

Model for LA block

A

QX-314 and QX-222 = permanently charged
Not cross membrane
Only block when introduce to cytosol
Bind cumulatively w/ depolarising pulse = use-dependent block
Not unbind at rest = open channel block
Block is voltage dependent - negative holding pulse can remove block

21
Q

LA pathways to access blocking site

A

Access blocking site in Na+ channel pore

Hydrophilic or hydrophobic

22
Q

Hydrophilic pathway

A

Clinically useful LA = highly lipophilic (cross membranes)
LA solutions = acidic (from HCl salts), increase drug solubility, mostly charged form
Inject - buffering system in tissue increase pH of solution, establish equilibrium, increase uncharged form, can cross cell membrane
LA interconvert to BH+ in cytosol - block channel from intracellular side
Block and recovery - need open channels

23
Q

Hydrophobic pathway

A

Experiment:
Hydrophilic analogue of lidocaine (GEA-968) - low lipid solubility
Show diff. route for drug access
Uncharged (B) gain direct access to channel through membrane
Hydrophobic LA - bind/unbind/leak out when channel closed
Low extracellular pH - slow leakage LA, extracellular H+ access LA in pore at rest
Leak from closed channels depend on lipid solubility of LA
Crystal structure of V-G Na+ channel - show side portals give hydrophobic access to central cavity

24
Q

Other channels blocked by LA

A

LA = +ve charge - enter many cation channels, block cation currents
Nicotinic acetylcholine receptor
Ryanodine receptor
K+ channels

25
Other clinical uses of LA
Anti-arrhythmic properties: If associate and dissociate before next HB, useful for treat arrhythmias (lidocaine) Block Na+ channels in heart
26
Tetrodotoxin (TTX)
Not LA More specific and potent blocker Na+ channels Enter extracellularly Not easy cross nerve sheath/ perineuronal tissues surrounding bundles of neurons
27
Metabolism
Esters: Procaine, tetracaine Rapidly metabolised in blood by plasma cholinesterases/ liver esterase's Amides: lidocaine, bupivacaine Widely distribute by circulation, only metabolise by liver enzymes, longer half-life/ duration
28
Factors influencing absorption
Dose, site of injection, drug-tissue binding, presence of vasoconstriction agents (loss LA from site of local application into circulation, prolong effect and reduce circulation of LA if vasoconstricting agent given)
29
Toxic action/ side effects
Result escape XS LA into systemic circulation | Toxicity more likely w/ impaired liver function (reduced break down of LA)
30
CNS toxicity
Light headed, leading to convulsions, respiratory depression, coma Brain - block inhibitory neurons = excitatory symptoms (trembling, tingle round mouth, fits, coma)
31
Cardiovascular toxicity
myocardial depression - reduce HR, SV Vasodilation Reduce BP
32
Administration
Surface application (nose, mouth, cornea, brachial tree, urinary tract) Direct injection into tissue for minor/ oral surgery (w/ vasoconstrictor e.g. adrenaline/felypressin) *Can't predict from injection how much reach spec. location Injection close to nerve trunk - brachial plexus, intercostal/dental nerves (increase rate of systemic absorption) Regional anaesthesia for limb surgery Spinal anaesthesia - act on spinal roots and spinal cord Epidural anaesthesia - act on spinal roots
33
Intravenous regional anaesthesia
Drug inject intravenously Distal to pressure cuff on limb Used prilocaine in past - lowest risk of cardiac toxicity, short acting Now - nerve block
34
Spinal anaesthesia
Inject into subarachnoid space Below outer membranes covering spinal chord Between 2nd and 5th lumbar vertebrae Major surgery (e.g. Caesarean section)
35
Epidural anaesthesia
Inject into epidural space Outside dura matter Direct action on nerve roots + spinal cord following diffusion across dura Use in obstetrics
36
Sequence of blockade
Pain - general sensory - motor Sequential block of different types of nerve fibre as exposed to LA Small diameter axons more sensitive than large Myelinated more sensitive than non
37
Nociceptor-specific anaesthesia
Current LA - block pain + tactile input + motor signals Prefer - pain selective block Target small unmyelinated C-fibres, selectively express TRPV1 channel, activated by capsaicin (in chilli)
38
Pharmacodynamics
What a drug does to the body
39
Pharmacokinetics
What the body does to a drug (metabolism)
40
Use-dependent block
LA drug bind Bettie to inactivated channel Must first activate (neuron fired) to become inactivated More neuron fired = more inactive channels = more binding LA